| Literature DB >> 21593293 |
Paul Benitez-Aguirre1, Maria E Craig, Muhammad Bayu Sasongko, Alicia J Jenkins, Tien Yin Wong, Jie Jin Wang, Ning Cheung, Kim C Donaghue.
Abstract
OBJECTIVE: To examine the association between retinal vascular geometry and subsequent development of incident retinopathy in young patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: A prospective cohort study of 736 people with type 1 diabetes aged 12 to 20 years, retinopathy-free at baseline, attending an Australian tertiary care hospital. Retinopathy was determined from seven-field retinal photographs according to the modified Airlie House Classification. Retinal vascular geometry, including length/diameter ratio (LDR) and simple tortuosity (ST), was quantified in baseline retinal photographs. Generalized estimating equations were used to determine risk of retinopathy associated with baseline LDR and ST, adjusting for other factors.Entities:
Mesh:
Year: 2011 PMID: 21593293 PMCID: PMC3120178 DOI: 10.2337/dc10-2419
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112
Baseline characteristics by retinopathy status and LDRa quartiles
| Retinopathy | LDRa | |||||||
|---|---|---|---|---|---|---|---|---|
| No | Yes | 1st quartile | 2nd quartile | 3rd quartile | 4th quartile | |||
| Variable | ||||||||
| Incident retinopathy | 0/449 [0] | 287/287 [100] | 92/184 [50.0] | 68/184 [37.0] | 71/184 [38.6] | 56/184 [30.4] | 0.002 | |
| Male sex | 230/449 [1.2] | 128/287 [44.6] | 0.08 | 91/184 [49.5] | 96/184 [52.2] | 87/184 [47.3] | 84/184 [45.7] | 0.6 |
| Age (years) | 13.9 (13.0–15.2) | 13.4 (12.7–14.8) | 0.006 | 13.4 (12.8–14.8) | 13.7 (12.8–15.2) | 13.7 (12.8–15.1) | 13.9 (12.9–15.0) | 0.4 |
| Diabetes duration (years) | 4.4 (3.0–7.2) | 5.3 (3.8–8.6) | 0.005 | 5.4 (3.6–7.9) | 5.0 (3.2–8.2) | 4.6 (3.2–7.4) | 4.9 (2.9–7.4) | 0.3 |
| A1C (%) | 8.3 (1.2) | 8.8 (1.3) | <0.001 | 8.7 (1.4) | 8.5 (1.2) | 8.3 (1.3) | 8.5 (1.3) | 0.02 |
| SBP SDS | 0.15 (0.99) | 0.32 (0.93) | 0.03 | 0.46 (0.90) | 0.21 (0.91) | 0.15 (1.04) | 0.05 (0.99) | 0.001 |
| DBP SDS | 0.38 (0.79) | 0.47 (0.79) | 0.2 | 0.56 (0.81) | 0.42 (0.79) | 0.33 (0.80) | 0.35 (0.75) | 0.02 |
| BMI SDS | 0.64 (0.76) | 0.52 (0.81) | 0.05 | 0.63 (0.83) | 0.58 (0.70) | 0.59 (0.81) | 0.57 (0.81) | 0.9 |
| Cholesterol (mmol/L) | 4.2 (3.7–4.7) | 4.3 (3.7–4.8) | 0.6 | 4.2 (3.7–4.7) | 4.1 (3.6–4.6) | 4.3 (3.8–4.7) | 4.3 (3.8–4.9) | 0.1 |
| LogAER | 0.71 (0.33) | 0.68 (0.27) | 0.2 | 0.71 (0.31) | 0.72 (0.32) | 0.71 (0.31) | 0.65 (0.28) | 0.2 |
| MDI | 117/433 [27.0] | 47/281 [16.7] | 0.001 | 30/179 [16.8] | 43/183 [23.5] | 40/177 [22.6] | 51/175 [29.1] | 0.05 |
Normal data are depicted as mean (SD), skewed data as median (IQR), and proportions as n [%].
MDI, multiple daily injections.
*Comparison between retinopathy groups used the Student t test for normal data, Mann-Whitney U test for skewed data, and χ2 test for proportions.
†Comparisons between LDRa groups used ANOVA for normal data and the Tukey test for multiple comparisons. The Kruskal-Wallis test was used for non-normal data comparisons and χ2 test for proportions.
LDR and ST predict incident retinopathy in prospective GEE univariate and multivariate models
| Variable | Pts ( | Univariate | Multivariate 1 | Multivariate 2 | ||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||||
| LDRa | 736 | 287 | ||||||
| Quartile | ||||||||
| 1 (<19.8) | 184 | 92 | 1.9 (1.3–2.7) | 0.001 | 1.8 (1.2–2.7) | 0.003 | 1.8 (1.2–2.6) | 0.003 |
| 2 (19.8–65.6) | 184 | 68 | 1.3 (0.9–1.9) | 0.2 | 1.3 (0.9–2.0) | 0.2 | 1.3 (0.9–2.0) | 0.2 |
| 3 (65.6–114.2) | 184 | 71 | 1.2 (0.8–1.8) | 0.3 | 1.3 (0.9–2.0) | 0.2 | 1.3 (0.9–1.9) | 0.2 |
| 4 (>114.2) | 184 | 56 | Reference | Reference | Reference | |||
| STa | 736 | 287 | ||||||
| Quartile | ||||||||
| 1 (<1,091) | 184 | 66 | Reference | Reference | Reference | |||
| 2 (1,091–1,107) | 184 | 76 | 1.5 (1.0–2.2) | 0.03 | 1.6 (1.1–2.4) | 0.02 | 1.6 (1.1–2.3) | 0.02 |
| 3 (1,108–1,127) | 184 | 69 | 1.5 (1.1–2.2) | 0.03 | 1.5 (1.0–2.2) | 0.03 | 1.6 (1.1–2.4) | 0.02 |
| 4 (>1,127) | 184 | 76 | 1.6 (1.1–2.3) | 0.008 | 1.6 (1.1–2.4) | 0.02 | 1.5 (1.0–2.2) | 0.03 |
Pts, patients.
*Model 1 adjusted for age, sex, and diabetes duration.
†Model 2 adjusted for model 1 covariates plus A1C, DBP, BMI, total cholesterol, and relevant interactions (sex*A1C and sex*cholesterol).
LDRa and ST as predictors of incident retinopathy stratified by sex by prospective GEE univariate and multivariate models
| Variable | Male subjects ( | Female subjects ( | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Univariate | Multivariate | Univariate | Multivariate | |||||||
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||||
| LDRa | ||||||||||
| Quartile 1(<19.8) | 91 | 1.8 (1.1–2.9) | 0.01 | 2.1 (1.1–4.0) | 0.03 | 93 | 2.0 (1.1–3.7) | 0.02 | 1.7 (1.1–2.7) | 0.03 |
| Quartile 2 (19.8–65.6) | 96 | 0.9 (0.5–1.5) | 0.7 | 2.7 (1.4–5.5) | 0.004 | 88 | 2.0 (1.1–3.7) | 0.02 | 0.8 (0.5–1.4) | 0.5 |
| Quartile 3 (65.6–114.2) | 87 | 1.0 (0.6–1.6) | 0.9 | 2.2 (1.1–4.4) | 0.03 | 97 | 1.6 (0.9–3.0) | 0.1 | 1.0 (0.6–1.6) | 0.8 |
| Quartile 4 (>114.2) | 84 | Reference | Reference | 100 | Reference | Reference | ||||
| STa (×103) | ||||||||||
| Quartile 1 (<1,091) | 89 | Reference | Reference | 95 | Reference | Reference | ||||
| Quartile2 (1,091–1,107) | 93 | 1.8 (1.1–3.1) | 0.03 | 2.4 (1.3–4.2) | 0.003 | 91 | 1.3 (0.8–2.1) | 0.3 | 1.2 (0.7–2.0) | 0.6 |
| Quartile 3 (1,108–1,127) | 94 | 1.6 (0.9–2.8) | 0.1 | 2.0 (1.1–3.6) | 0.02 | 90 | 1.5 (0.9–2.5) | 0.08 | 1.4 (0.9–2.2) | 0.2 |
| Quartile 4 (>1,127) | 82 | 2.1 (1.2–3.6) | 0.01 | 2.4 (1.1–4.4) | 0.007 | 102 | 1.3 (0.8–2.2) | 0.2 | 1.1 (0.7–1.8) | 0.8 |
| Diabetes duration (years) | 1.2 (1.2–1.3) | <0.001 | 1.2 (1.2–1.3) | <0.001 | 1.2 (1.2–1.3) | <0.001 | 1.2 (1.0–1.3) | <0.001 | ||
| A1C | 1.2 (1.0–1.3) | 0.03 | 1.2 (1.1–1.4) | 0.001 | 0.9 (0.8–1.0) | 0.2 | — | |||
| Cholesterol | 1.4 (1.2–1.7) | 0.001 | 1.3 (1.1–1.5) | 0.01 | 1.0 (0.8–1.2) | 0.7 | — | |||
| DBP (mmHg) | 1.05 (1.03–1.07) | <0.001 | 1.04 (1.02–1.06) | 0.001 | 1.01 (1.00–1.03) | 0.1 | — | |||
| BMI (kg/m2) | 1.09 (1.04–1.13) | <0.001 | — | — | 1.14 (1.08–1.19) | <0.001 | 1.07 (1.03–1.12) | 0.001 | ||
In addition to LDR and ST:
*Male multivariate model included diabetes duration, A1C, total cholesterol, and DBP as significant covariates.
‡Female multivariate model included diabetes duration and BMI as significant covariates.